CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-25 | Gupta Suneel Chief Development Officer | Option exercise | +45,000 | $7.38 | $332K | 229,611 |
| 2024-11-25 | Gupta Suneel Chief Development Officer | Option exercise | +45,000 | $8.02 | $361K | 274,611 |
| 2024-11-25 | Gupta Suneel Chief Development Officer | Option exercise | +85,000 | $7.80 | $663K | 359,611 |
| 2024-11-25 | Gupta Suneel Chief Development Officer | Sale | −103,437 | $46.04 | $4.8M | 256,174 |
| 2024-11-25 | Gupta Suneel Chief Development Officer | Option exercise · Stock Option (right to buy) | −45,000 | 0 | ||
| 2024-11-25 | Gupta Suneel Chief Development Officer | Option exercise · Stock Option (right to buy) | −45,000 | 0 | ||
| 2024-11-25 | Gupta Suneel Chief Development Officer | Option exercise · Stock Option (right to buy) | −85,000 | 0 | ||
| 2024-11-25 | PATEL DINESH V PH D President and CEO | Sale | −78,520 | $46.96 | $3.7M | 435,208 |
| 2024-11-25 | PATEL DINESH V PH D President and CEO | Gift | −7,000 | 428,208 | ||
| 2024-11-25 | PATEL DINESH V PH D President and CEO | Option exercise | +1,727 | $21.58 | $37K | 429,935 |
| 2024-11-25 | PATEL DINESH V PH D President and CEO | Option exercise · Stock Option (right to buy) | −1,727 | 318,273 | ||
| 2024-11-19 | PATEL DINESH V PH D President and CEO | Gift | −1,000 | 513,415 | ||
| 2024-11-15 | MOLINA ARTURO MD Chief Medical Officer | Sale | −1,906 | $40.98 | $78K | 46,444 |
| 2024-09-11 | Ali Asif Chief Financial Officer | Sale | −2,203 | $44.59 | $98K | 34,960 |
| 2024-09-11 | Ali Asif Chief Financial Officer | Option exercise | +6,000 | $19.19 | $115K | 40,960 |
| 2024-09-11 | Ali Asif Chief Financial Officer | Option exercise | +6,000 | $12.17 | $73K | 46,960 |
| 2024-09-11 | Ali Asif Chief Financial Officer | Sale | −12,000 | $44.47 | $534K | 34,960 |
| 2024-09-11 | Ali Asif Chief Financial Officer | Option exercise · Stock Option (right to buy) | −6,000 | 76,500 | ||
| 2024-09-11 | Ali Asif Chief Financial Officer | Option exercise · Stock Option (right to buy) | −6,000 | 45,750 | ||
| 2024-09-10 | Waddill William D. Director | Option exercise 10b5-1 | +8,000 | $12.88 | $103K | 20,000 |
Page 11 of 29 · 580 trades